Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
Open Access
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 238 (2) , 336-343
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Availability and Quality of Coronary Heart Disease Family History in Primary Care Medical Records: Implications for Cardiovascular Risk AssessmentPLOS ONE, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia: Table 1Heart, 2009
- Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative CardiologyHeart, Lung and Circulation, 2008
- Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry studyEuropean Heart Journal, 2008
- The genome-enabled electronic medical recordJournal of Biomedical Informatics, 2007
- Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry studyBMJ, 2000
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991